The gut microbiome in pancreatogenic diabetes differs from that of Type 1 and Type 2 diabetes

被引:0
作者
Rupjyoti Talukdar
Priyanka Sarkar
Aparna Jakkampudi
Subhaleena Sarkar
Mohsin Aslam
Manasa Jandhyala
G. Deepika
Misbah Unnisa
D. Nageshwar Reddy
机构
[1] Asian Healthcare Foundation,Pancreas Research Group and Division of Gut Microbiome Research, Wellcome DBT India Alliance Laboratories, Institute of Basic and Translational Research
[2] Asian Institute of Gastroenterology,Department of Medical Gastroenterology
[3] Asian Institute of Gastroenterology,Department of Endocrinology
[4] Asian Institute of Gastroenterology,Department of Biochemistry
[5] Asian Institute of Gastroenterology,undefined
来源
Scientific Reports | / 11卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
We hypothesized that the gut microbiome in patients with diabetes secondary to chronic pancreatitis (Type 3c) is different from those with Type 1 and Type 2 diabetes. This was a cross-sectional preliminary study that included 8 patients with Type 1, 10 with Type 2, 17 with Type 3c diabetes and 9 healthy controls. Demographic, clinical, biochemical, imaging and treatment data were recorded and sequencing of the V3–V4 region of the bacterial 16SrRNA was done on fecal samples. Bioinformatics and statistical analyses was performed to evaluate the differences in the diversity indices, distance matrices, relative abundances and uniqueness of organisms between the types of diabetes. There was significant difference in the species richness. Beta diversity was significantly different between patients with Type 3c diabetes and the other groups. 31 genera were common to all the three types of diabetes. There was significant differences in the species level taxa between Type 3c diabetes and the other groups. The unique bacterial species signature in Type 3c diabetes compared to Type 1 and Type 2 diabetes included Nesterenkonia sp. AN1, Clostridium magnum, Acinetobacter lwoffii, Clostridium septicum, Porphyromonas somerae, Terrabacter tumescens, and Synechococus sp.
引用
收藏
相关论文
共 97 条
  • [1] Das A(2015)Type 1 diabetes in India: overall insights Indian J. Endocr. Metab. 19 31-237
  • [2] Aslam M(2020)Reduced pancreatic polypeptide response is associated with early alteration of glycemic control in chronic pancreatitis Diabetes Res. Clin. Pract. 160 107993-136
  • [3] Vijayasarathy K(2016)Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer Lancet Gastroenterol. Hepatol. 1 226-236
  • [4] Talukdar R(2017)Chronic pancreatitis in Eastern India: Experience from a tertiary care center Indian J. Gastroenterol. 36 131-599
  • [5] Sasikala M(2014)Clinical profile of early-onset and late-onset idiopathic chronic pancreatitis in South India Indian J. Gastroenterol. 33 231-371
  • [6] Nageshwar Reddy D(2009)Clinical profile of idiopathic chronic pancreatitis in North India Clin. Gastroenterol. Hepatol. 7 594-8803
  • [7] Hart PA(2015)Demographic and clinicopathological profile of patients with chronic pancreatitis in a tertiary referral teaching hospital of West Bengal: Personal experience Indian J. Gastroenterol. 34 365-352
  • [8] Jha AK(2015)Role of the normal gut microbiota World J. Gastroenterol. 21 8787-40
  • [9] Goenka MK(2016)Gut microbiota, metabolites and host immunity Nat. Rev. Immunol. 16 341-2395
  • [10] Goenka U(2017)Chemical transformation of xenobiotics by the human gut microbiota Science 356 6344-568